WikiDoc Resources for Exinct |
Articles |
---|
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Exinct at Clinical Trials.gov Clinical Trials on Exinct at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Exinct
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Directions to Hospitals Treating Exinct Risk calculators and risk factors for Exinct
|
Healthcare Provider Resources |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Exinct stands for extended inhibitory context. It was first described by Singh and coworkers to define a negative sequence within the coding region of SMN2 gene [1] [2] [3]. Thanks to presence of Exinct, SMN2 gene is not able to produce the normal protein. In fact, Exinct causes aberrant splicing of exon 7, leading to the production of a short SMN transcript that makes a truncated non-functional SMN protein. Inability of SMN2 to make the full-length protein causes spinal muscular atropy (SMA), a debalitating disease of children and infant [4].